Intranasal beclomethasone in severe rhinosinusitis and nasal polyps.

Abstract	The study was designed to measure the effect of inhaled beclomethasone on patients with severe symptomatic rhinosinusitis and nasal polyposis following 12 weeks of therapy. Only one of eight patients had improved nasal symptoms and a reduction in the degree of nasal obstruction. Except for an occasional patient intranasal beclomethasone in the recommended dosage is not effective in the management of chronic severe symptomatic rhinosinusitis.
Authors	H A Krouse, N D Phung, W B Klaustermeyer
Journal	Annals of allergy (Ann Allergy) Vol. 50 Issue 6 Pg. 385-8 (Jun 1983) ISSN: 0003-4738 [Print] United States
PMID	6344703 (Publication Type: Clinical Trial, Journal Article)
Chemical References	Aerosols Beclomethasone
Topics	Administration, Intranasal Adult Aerosols Aged Beclomethasone (administration & dosage, therapeutic use) Clinical Trials as Topic Female Humans Male Maxillary Sinus (diagnostic imaging) Middle Aged Nasal Polyps (diagnostic imaging, drug therapy) Sinusitis (diagnostic imaging, drug therapy) Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!